Healthcare Sector — activité des initiés

Suivez les achats et ventes d’initiés sur les actions de Healthcare. Découvrez quels dirigeants achètent, l’activité nette des initiés et le pourcentage du flottant échangé parmi 3,435 sociétés.
Les informations fournies dans ce classement sont à titre informatif uniquement et ne constituent pas un conseil financier. Nous ne recommandons aucun investissement spécifique basé sur ces critères.
Entreprises
Données
Abonnez-vous pour accéder à l'ensemble des données
Entreprise Secteur d'activité Cap. boursière ($) # acheteurs nets Valeur nette achetée ($) % du flottant acheté % d'actions détenues par les initiés
Pharmaceuticals & Medical Research Mega (1.3tn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mega (664.9bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (513.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (368.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mega (333.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (311.2bn) 0 Aucune activité — —
CH Novartis AG (NOVN)
Pharmaceuticals & Medical Research Mega (303.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mega (257.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Mega (249.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (249.4bn) 1–5 $10M–$100M 0–15% 0–15%
Pharmaceuticals & Medical Research Mega (210.0bn) 0 Aucune activité — 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals & Medical Research Mega (201.4bn) 0 Aucune activité — 0–15%
Healthcare Services Large (199.9bn) -1–5 -$10M–$100M -0–15% 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (174.0bn) 0 Aucune activité — 0–15%
Healthcare Services Large (163.1bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (152.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (137.5bn) 0 Aucune activité — 0–15%
Healthcare Services Large (134.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (129.3bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (128.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (107.4bn) 0 Aucune activité — 0–15%
Healthcare Services Large (105.5bn) -1–5 -$10M–$100M -0–15% 15–50%
Healthcare Services Large (104.1bn) 1–5 $1M–$10M 0–15% 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (101.5bn) 0 Aucune activité — 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals & Medical Research Large (97.8bn) 0 Aucune activité — 0–15%
Healthcare Services Large (93.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (93.4bn) -1–5 -$10M–$100M -0–15% 0–15%
GB GSK plc (GSK)
Pharmaceuticals & Medical Research Large (92.8bn) 11–20 $100K–$1M 0–15% 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals & Medical Research Large (90.6bn) 0 Aucune activité — 0–15%
Healthcare Services Large (80.4bn) 0 Aucune activité — 0–15%
Healthcare Services Large (79.6bn) 1–5 < $100K 0–15% 15–50%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 Aucune activité — —
Healthcare Services Large (64.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (64.2bn) 1–5 $100K–$1M 0–15% 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (62.0bn) 0 Aucune activité — 0–15%
BE Ucb SA (UCB)
Pharmaceuticals & Medical Research Large (61.9bn) 1–5 < $100K 0–15% 15–50%
DE Bayer AG (BAYN)
Pharmaceuticals & Medical Research Large (61.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (60.7bn) -6–10 -$10M–$100M -0–15% 0–15%
US Natera, Inc. (NTRA)
Healthcare Services Large (59.7bn) 0 Aucune activité — 0–15%
Healthcare Services Large (58.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (58.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (56.6bn) -1–5 -$1M–$10M -0–15% 0–15%
NL argenx SE (ARGX)
Pharmaceuticals & Medical Research Large (55.9bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (52.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (52.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (51.5bn) 0 Aucune activité — 50%+
US Humana Inc. (HUM)
Healthcare Services Large (50.8bn) 0 Aucune activité — 0–15%
Healthcare Services Large (50.0bn) -1–5 -< $100K -0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (48.2bn) -1–5 -$100M+ -0–15% 0–15%
US Waters Corp (WAT)
Healthcare Services Large (46.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (44.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (44.7bn) 0 Aucune activité — 50%+
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (42.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (39.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (39.0bn) 0 Aucune activité — 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals & Medical Research Large (37.7bn) 1–5 $100K–$1M 0–15% 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (36.8bn) 0 Aucune activité — 0–15%
Healthcare Services Large (36.5bn) 0 Aucune activité — 0–15%
US Centene Corp (CNC)
Healthcare Services Large (33.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Illumina Inc (ILMN)
Healthcare Services Large (33.4bn) -1–5 -$100M+ -0–15% 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (33.1bn) 0 Aucune activité — 0–15%
KR Celltrion, Inc. (068270)
Pharmaceuticals & Medical Research Large (32.7bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (32.0bn) 0 Aucune activité — 50%+
US Dexcom Inc (DXCM)
Healthcare Services Large (31.1bn) 0 Aucune activité — 0–15%
CH Alcon AG (ALC)
Healthcare Services Large (30.8bn) 0 Aucune activité — 0–15%
Healthcare Services Large (29.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (29.7bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Large (29.2bn) 1–5 -$100K–$1M -0–15% 50%+
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (28.9bn) 0 Aucune activité — 0–15%
Healthcare Services Large (28.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (28.2bn) 0 Aucune activité — 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 Aucune activité — 0–15%
DK Genmab A/S (GMAB)
Pharmaceuticals & Medical Research Large (27.5bn) 0 Aucune activité — 0–15%
Healthcare Services Large (26.8bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (26.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (25.9bn) -1–5 -$10M–$100M -0–15% 15–50%
IE STERIS plc (STE)
Healthcare Services Large (25.0bn) 0 Aucune activité — 0–15%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (24.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (24.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (24.0bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Large (24.0bn) -1–5 -$1M–$10M -0–15% 0–15%
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 Aucune activité — 0–15%
DE Biontech SE (BNTX)
Pharmaceuticals & Medical Research Large (23.1bn) -1–5 -$10M–$100M -0–15% 50%+
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (22.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (22.4bn) -6–10 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (21.2bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (21.1bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (21.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (19.4bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Large (18.8bn) -6–10 -$100M+ -0–15% 15–50%
Healthcare Services Large (18.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (18.4bn) 1–5 $100K–$1M 0–15% 15–50%
DE Sartorius AG (SRT)
Healthcare Services Large (17.7bn) 0 Aucune activité — 50%+
US Revvity, Inc. (RVTY)
Healthcare Services Large (17.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (17.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (17.3bn) -1–5 -$100K–$1M -0–15% 0–15%